For the year ending 2025-12-31, PDSB has $30,494,083 in assets. $21,242,250 in debts. $26,711,969 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 26,711,969 | |||
| Prepaid expenses and other assets | 1,542,116 | |||
| Total current assets | 28,254,085 | |||
| Prepaid expenses | 1,996,300 | |||
| Property and equipment | 295,911 | |||
| Less accumulated depreciation | 175,727 | |||
| Property and equipment, net | 120,184 | |||
| Financing lease right-of-use assets | 123,514 | |||
| Total assets | 30,494,083 | |||
| Accounts payable | 3,574,448 | |||
| Accrued expenses | 742,227 | |||
| Current portion of notes payable | 5,130,372 | |||
| Financing lease obligation - short term | 36,167 | |||
| Total current liabilities | 9,483,214 | |||
| Note payable, net of current portion | 11,733,350 | |||
| Financing lease obligation-long term | 25,686 | |||
| Total liabilities | 21,242,250 | |||
| Common stock, 0.00033 par value, 150,000,000 shares authorized at december 31, 2025 and december 31, 2024, 54,878,233 shares and 37,987,380 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 18,111 | |||
| Additional paid-in capital | 225,840,226 | |||
| Accumulated deficit | -216,606,504 | |||
| Total stockholders' equity | 9,251,833 | |||
| Total liabilities and stockholders' equity | 30,494,083 | |||
PDS Biotechnology Corp (PDSB)
PDS Biotechnology Corp (PDSB)